Platinum vs non-platinum chemotherapy regimes for small cell lung cancer

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2007, Pages

  Amarasena, Isuru ^a   Walters, J ^b   Wood Baker, R ^b   Fong, K ^b  

^a UNIVERSITY OF TASMANIA   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; IFOSFAMIDE; PLATINUM COMPLEX; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; HUMAN; LUNG SMALL CELL CANCER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 44949161075     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006849     Document Type: Review

References (14)

1. Berghmans 1999 Berghmans T, Paesmans M, Mascaux C, et al.A meta-analysis of the role of etoposide (VP-16) and cisplatin (CDDP) in small cell lung cancer (SCLC) with methodology assessment. Eur. J. Cancer 1999;35(Suppl 4):248.
2. Cohen 1978 Cohen EA, Mathews MJ. Small cell bronchogenic carcinoma: A distinct clinico-pathological entity. Semin Oncol 1978;5:234-243.
3. Doll 1978 Doll R, Peto R. Cigarette Smoking and Bronchial Carcinoma: Dose and Time Relationships Among Regular Smokers and Lifelong non-Smokers. J Epidemiol Community Health 1978;32(4):303-13.
4. Ferlay 2001 Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000 Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base 2001, issue 5.
5. Fukuoka 1991 Fukuoka M, Furuse K, Saijo N, Nishiwaki Y, Ikegami H, Tamura T, Shimoyama M. Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. J. Natl. Cancer Inst 1991;83:855-861.
6. Kato 1969 Kato Y, Fergusson TB, Bennett DE, et al.Oat cell carcinoma of the lung. A review of 13 cases. Cancer 1969;23:517- 524.
7. Lassen 1995 Lassen U, Osterlind K, Hansen M, Dombernowsky P, Bergman B, Hansen HH. Long-term survival in small cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years - an analysis of 1714 consecutive patients. J. Clin. Oncol 1995;13:1215-20.
8. Le Pechoux 2004 Le Pechoux C, Dhermain F, Bretel JJ, et al.Modalities of radiotherapy in small cell lung cancer: thoracic radiotherapy and prophylactic cerebral irradiation. Rev. Pneumol. Clin 2004;3S:91-103.
9. Pujol 2000 Pujol JL, Carestia L, Daures JP. Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent. British J. Cancer 2000;83(1):8-15.
10. Robinson 2002 Robinson KA, Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. Int J Epidemiol 2002;31(1):150-3. [MEDLINE: 11914311].
11. Rosenberg 1965 Rosenberg B, Vn Camp L, Krigas T. Inhibition of cell division in Eschericia coli by electrolysis products from a platinum electrode. Nature 1965;205:698-699.
12. Souhami 1990 Souhami RL, Law K. A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research. Br. J. Cancer 1990;61:584-9.
13. Stahel 1989 Stahel R, Aisner J, Ginsberg R, Havemann K, Hirsch F, Ihde D, Jassem J, Karrer K, Maurer H, van Houtte P, Osterlind K. Staging and prognostic factors in small cell lung cancer. Lung Cancer 1989;5:119-126.
14. van Loon 1997 van Loon AJ, Kant IJ, Swaen GM, Goldbohm RA, Kremer AM, van den Brandt PA. Occupational exposure to carcinogens and risk of lung cancer: results from The Netherlands cohort study. Occup Environ Med 1997;54(11):817-24.